OnKure closes $7M Series A financing round to advance drug development

OnKure closes $7M Series A financing round to advance drug development

BOULDER -- OnKure, Inc. , the epigenetics-focused drug discovery and development company advancing the first Largazole-derived, histone deacetylase inhibitor into Phase 1 clinical trials,... Read More

Thursday May 3, 2018 0 comments Tags: Boulder, OnKure Therapeutics, Delian Capital, Tony Piscopio